HilleVax, Inc.HilleVax, Inc. • March 20th, 2024 • Biological products, (no disgnostic substances) • New Jersey
Company FiledMarch 20th, 2024 Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to offer you a position on the terms set forth in this letter (this “Agreement”), effective as of January 16, 2024.
HILLEVAX, INC.HilleVax, Inc. • March 17th, 2023 • Biological products, (no disgnostic substances) • Massachusetts
Company FiledMarch 17th, 2023 Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this amended and restated offer letter (this “Agreement”). This Agreement is entered into effective January 6, 2023 and amends and restates in its entirety the offer letter between the Company and you that was dated November 16, 2021 (the “Prior Agreement”).
HilleVax, Inc.HilleVax, Inc. • March 17th, 2023 • Biological products, (no disgnostic substances) • California
Company FiledMarch 17th, 2023 Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this second amended and restated offer letter (this “Agreement”). This Agreement is entered into effective January 6, 2023 and amends and restates in its entirety the amended and restated offer letter between the Company and you that was dated March 1, 2021 (the “Prior Agreement”).